Background: Fetal aortic valvuloplasty (FAV) is proposed to prevent hypoplastic left heart syndrome due to fetal critical aortic stenosis.
Objective: to report our experience on FAV as the first step in a complex therapeutic strategy.
Method: Series of patients with FAV over an 18-year period.